当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.inclusion criteria

inclusion criteria

Patients with anterior neck pain as the chief complaint
/
Doctors suspect patients with subacute thyroiditis

1.2.exclusion criteria

Patients with one of the following exclusion criteria

1.3.doctor name

doctor name

熊周怡

2.Baseline
2.1.General information

patient name

卢德政

birthday

1962-03-28

gender

male

nation

Han

ABO blood type

unidentified

RH blood type

unidentified

certificate type

identity card

ID number

44022319620328001X

place of residence

广东省韶关市南雄市

marital status

married

Highest Education Level

senior high school

occupation

worker
/
farmer

medical insurance

Basic medical insurance for urban workers

name of contact

phone

2.2.Medical information
2.2.2.2.2.1、first

content

outpatient

hospital name

前海医院

register number

date of hospital visiting

2023-04-20

department

内科

current diagnose

肺炎

Consistent with the final diagnosis

no

2.2.2.2.2.2、second

content

inpatient

hospital name

粤北人民医院

register number

02500035

date of hospital visiting

2023-04-25

department

呼吸内科

current diagnose

发热查因

Consistent with the final diagnosis

no

2.2.2.2.2.3、third

content

inpatient

hospital name

粤北人民医院

register number

02500035

就诊日期/住院日期

2023-05-05

department

内分泌科

current diagnose

亚急性甲状腺炎

Consistent with the final diagnosis

yes

2.2.2.2.2.4、fourth

content

hospital name

register number

date of hospital visiting

department

current diagnose

Consistent with the final diagnosis

2.2.2.2.2.5、onset situation

Whether the first visiting

no

onset season

spring

recurrent

no

Time of first attack

2.3.Relevant medication status before treatment
2.2.3.2.3.1、Whether the drug use

whether the drug

2.2.3.2.3.2、drug1

drug name

头孢

doseage

不详

unit of doseage

pill

administration route

po

Dosing frequency

bid

start date

2023-04-20

time of duration(days)

10

2.2.3.2.3.3、drug2

drug name

doseage

unit of doseage

administration route

Dosing frequency

start date

time of duration(days)

2.2.3.2.3.4、drug3

drug name

doseage

unit of doseage

administration route

Dosing frequency

start date

time of duration(days)

2.4.Physical examination

Vital signs and laboratory examination

Yes

date

2032-04-25

2.2.4.2.4.2、system

overall appearance

normal

EENT

normal

head

normal

lung

normal

abdoman

normal

Spinal&limbs

normal

2.2.4.2.4.4、vital signs

height(cm)

165

weight(kg)

68

BMI(KG/M2)

24.98

waistline(cm)

body temperature(°C)

36.3

pulse(bpm)

84

heart rate(bpm)

84

breathe(bpm)

20

diastolic pressure(mmHg)

60

systolic pressure(mmHg)

132

2.2.4.2.4.5、thyroid pain

degree

mild

location

both side

time of duration(days)

15

Whether it is the first symptom

no

2.2.4.2.4.6、fever

time of duration(days)

15

Whether it is the first symptom

yes

degree

Moderate fever

2.2.4.2.4.7、cold before onset

yes/no

no

time of duration(days)

Whether it is the first symptom

2.2.4.2.4.8、radiation pain

yes/no

yes

location

time of duration(days)

15

Whether it is the first symptom

no

2.2.4.2.4.9、paopitation

yes/no

yes

time of duration(days)

15

Whether it is the first symptom

no

2.2.4.2.4.10、tremble

yes/no

yes

time of duration(days)

15

Whether it is the first symptom

no

2.2.4.2.4.11、weight lose

yes/no

no

time of duration(days)

Whether it is the first symptom

2.2.4.2.4.12、goiter

yes/no

mild

location

right

time of duration(days)

10

Whether it is the first symptom

no

2.2.4.2.4.13、thyroid tenderness

yes/no

medium

location

both side

time of duration(days)

15

Whether it is the first symptom

no

2.5.allergic history

yes/no

no

allergen

2.6.Relevant Family History

Type of Family Medical History

kinship

2.7.Personal medical history and past history

if has hypertension

yes

if has diabetes

yes

if has coronary heart disease

yes

2.8.laboratory examination
2.2.8.2.8.1、blood routine

WBC

8.2 ×109 /L

NEUT%

77.3 %

LY%

%

MONO%

RBC

×10^12 /L

HGB

g/L

PLT

×10^9 /L

Researcher signature

熊周怡

Date

2023-04-26 yyyy-mm-dd

2.2.8.2.8.2、Inflammatory biomarkers

ESR(mm/h)

100

C-reaction protein(Mg/ml)

30.79

2.2.8.2.8.3、thyroid function

Thyroid stimulating hormone, TSH

0.008 uIU/ml

FT3

14 pmol/L

FT4

70 pmol/L

Anti-TG

571 IU/ml

Anti-TP0

140 IU/ml

Diagnosed as

Hyperthyroidism

2.2.8.2.8.4、thyroid antibody

TRAb(IU/L)

2.9.影像学检查
2.2.9.2.9.1、thyroid ECT

Thyroid morphology

unclear

Taken technetium function

decrease

description

甲状腺显影不清,摄锝功能减低

2.2.9.2.9.2、thyroid B-type ultrasound

thyroid enlargement

isthmus

left lobe width(mm)

left lobe thickness

right lobe width(mm)

right lobe thickness(mm)

isthmus thickness(mm)

echo

Echo weakened

Blood flow situation

normal

decribe

甲状腺增大并回声异常,桥本?请结合实验室检查

2.10.FNAC

Based site

pathology results

description

2.11.diagnostic scale

Thyroid tenderness(6 scores)

yes

Firm on palpation(3 scores)

yes

Increased ESR(3 scores)

yes

elevated thyroid hormone level(2 scores)

yes

total score

14

3.SOPs
3.1.Treatment SOP
3.2.
3.3.Data management system
3.4.ADR/ADE management system
4.Research team
4.1.institutions
4.2.researchers
5.Design, Methods
5.1.Calculation of sample size
6.Management for Progress

Whether got the informed consent?

Date of sign the informed consent

xx年xx月xx日